Chemotaxis is the directed migration of cells along a chemical concentration gradient, and it drives cellular movement and immunity by allowing cells to sense minute differences in attractant concentration across their own length and steer toward the source. Neutrophils, macrophages, and dendritic cells depend on this steering to reach infection sites, and an error of just a few percent in gradient sensing can misroute an entire immune response.
The sensing machinery inside a moving cell
A cell does not measure an absolute chemical concentration. It measures the difference between its front and back, and that difference is tiny. A neutrophil is roughly 10 micrometers across, and under typical tissue conditions the attractant concentration changes only a few percent from one end of the cell to the other. Receptors must resolve that shallow slope and convert it into a polarized internal signal.
The core logic works like this. G-protein-coupled receptors bind chemoattractants such as CXCL8 (interleukin-8) or complement fragment C5a. Binding activates small GTPases, chiefly Rac at the leading edge and RhoA toward the rear. Rac drives actin polymerization that pushes the front membrane forward. RhoA activates myosin contractility that retracts the tail. The cell becomes a self-organizing engine: front advances, back releases, and the axis of polarity points up the gradient.
Two properties make this work. First, receptors adapt. A cell exposed to a uniform high concentration stops responding within minutes, which resets its dynamic range so it can detect new gradients. Second, the internal response is amplified. Signaling loops convert a 2 percent external difference into a near-total internal asymmetry. Without amplification, the shallow external slope would be lost in molecular noise.
The plain-language version: the cell compares its front to its back, exaggerates the difference internally, and crawls toward the better side.
How the gradient becomes directed motion
Directional migration proceeds through four coupled steps. Protrusion extends the leading edge. Adhesion anchors the new front to the substrate. Contraction pulls the cell body forward. Rear release detaches the trailing edge. Each step is chemically regulated, and the sequence repeats in cycles of roughly 30 to 120 seconds depending on cell type and substrate.
Neutrophils are fast. They can migrate at 10 to 20 micrometers per minute in interstitial tissue, reaching a wound or bacterial focus within tens of minutes when the distance is short. Dendritic cells are slower and deliberate; they sample antigen in peripheral tissue and then travel to lymph nodes over hours to days, guided by the chemokine receptor CCR7 responding to CCL19 and CCL21.
The gradient itself is often not a smooth line. Chemoattractants bind extracellular matrix, are degraded by enzymes, and are consumed by the responding cells. This creates steep local gradients near the source and flatter fields farther away. Cells integrate over time, comparing recent concentrations rather than instantaneous ones, which filters noise and stabilizes direction.
Speed and accuracy trade off. A cell that moves very fast samples the gradient briefly and turns less precisely. A slow cell averages more signal and steers better but takes longer to arrive.
Numbers that frame the response
Concrete magnitudes help calibrate intuition, and they differ sharply by cell type.
| Cell type | Typical speed | Primary attractants | Time to target |
|---|---|---|---|
| Neutrophil | 10–20 µm/min | CXCL8, C5a, fMLP | Minutes to tens of minutes |
| Macrophage | 5–15 µm/min | CCL2, C5a | Tens of minutes to hours |
| Dendritic cell | 2–10 µm/min | CCL19, CCL21 | Hours to days |
| T lymphocyte | 5–15 µm/min | CXCL12, CCL21 | Hours |
| Fibroblast | 10–40 µm/day | PDGF, TGF-β | Days |
Note the unit mismatch: immune cells are measured per minute, fibroblasts per day. Comparing them directly without conversion misleads.
Gradient steepness matters as much as absolute concentration. Many leukocytes orient reliably when the concentration changes by roughly 2 to 10 percent across the cell length. Below about 1 percent, orientation becomes erratic. Above roughly 20 percent, the response saturates and the cell may stop distinguishing further increases.
Receptor occupancy follows the same logic. At very low attractant levels, too few receptors are bound to produce a reliable signal. At very high uniform levels, all receptors are occupied and adaptation silences the cell. The usable sensing window therefore sits between those extremes, and it shifts as receptors adapt.
Edge cases and counterintuitive behavior
The intuitive picture is a cell marching straight up a gradient. Real behavior is messier, and several findings contradict the simple model.
Cells can move away from a repellant rather than toward an attractant, and some guidance cues act as repellents at one concentration and attractants at another. This concentration-dependent sign reversal appears with certain chemokines and is one reason simple "attractant equals go" assumptions fail.
Cells also navigate by memory and by comparison, not by instantaneous reading. When a gradient is briefly removed, a polarized neutrophil can continue in its prior direction for a short period before repolarizing. This persistence helps it push through obstacles but can send it past a target if the gradient changes fast.
Perhaps the most counterintuitive detail: chemokinesis and chemotaxis are different. Chemokinesis is a change in random movement speed without directionality. A cell can speed up in response to a chemical without steering anywhere. Many assays that appear to show chemotaxis actually measure increased random motility, which is why gradient-controlled experiments matter.
A uniform concentration of attractant abolishes directed migration even though the chemical is present. Adaptation can make a cell transiently blind immediately after a sudden concentration jump. Some pathogens secrete factors that desensitize host receptors and blunt recruitment. Dense tissue and matrix binding can flatten gradients until they fall below the sensing threshold. Overlapping attractant sources can create conflicting signals and reduce targeting accuracy.
Where the model misleads
The dominant misconception is that chemotaxis is a single, uniform process. It is a family of mechanisms tuned to cell type, tissue, and context, and the same molecule can guide different cells in opposite directions.
A second misconception treats gradient sensing as instantaneous and perfect. Real cells face noise, receptor saturation, and adaptation, all of which limit precision. A third treats in vitro speed as in vivo speed; migration through matrix, endothelium, and interstitial fluid is slower and more constrained than movement across a glass slide.
There is also a professional caveat worth stating plainly. Many published chemotaxis measurements use different gradient units, different substrates, and different time windows, so cross-study comparison is often invalid. Treat any single speed figure as context-specific rather than universal.
Practical actions for interpreting and supporting chemotaxis
For researchers, clinicians reading immunology literature, and anyone evaluating claims about immune cell guidance, a few concrete steps improve accuracy.
Confirm the gradient is controlled. A response to a uniform chemical is chemokinesis, not chemotaxis. Record the gradient steepness in percent change across cell length, not just the absolute concentration. Match the time window to the cell type; minute-scale assays miss dendritic cell behavior. Note the substrate and matrix, since adhesion conditions change speed substantially. Distinguish directed migration from increased random speed before drawing conclusions. Check for receptor adaptation when responses fade despite sustained stimulation.
These checks reconcile apparently conflicting results. Two studies reporting different neutrophil speeds may both be correct if their gradients, substrates, and time windows differ. The thresholds to compare are gradient steepness, absolute concentration, and assay duration; when those align, speed figures usually converge.
Limits of what current evidence supports
The mechanisms described here are well established, but several open questions remain, and certainty should be stated carefully.
How cells integrate multiple simultaneous gradients is incompletely understood. Whether one cue dominates or signals are averaged appears context-dependent, and no universal rule is confirmed. How adaptation timing is set molecularly varies by receptor and cell type.
Clinical translation is limited. Attempts to therapeutically manipulate chemotaxis have faced difficulty because blocking one attractant pathway often leaves redundant routes intact, and because systemic blockade can impair host defense. No broadly adopted chemotaxis-targeting therapy exists, and claims otherwise should be treated skeptically.
Measurement standardization also lags. Without agreed units and assay conditions, comparing results across studies remains unreliable. The safe conclusion is mechanistic: cells sense shallow gradients, amplify them internally, polarize, and crawl, and immunity depends on this steering working within tight tolerances.